• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同正畸治疗对错牙合畸形患者痰液趋化因子CX3CL1、RANKL/OPG水平的影响]

[Effects of different orthodontic treatments on sputum chemokines CX3CL1, RANKL/OPG levels in patients with malocclusion].

作者信息

Lin Jia-Xu, Zhang Ru-Hong, Zhang Jian-Na, Wu Xiao-Ping

机构信息

Department of Stomatology, Shantou Central Hospital. Shantou 515000, Guangdong Province, China. E-mail:

出版信息

Shanghai Kou Qiang Yi Xue. 2021 Feb;30(1):85-88.

PMID:33907786
Abstract

PURPOSE

To investigate the effects of different orthodontic treatments on gingival crevicular fluid chemokine CX3CL1, nuclear factor κB receptor activating factor ligand/osteoprotegerin(RANKL/OPG) levels in patients with malocclusion.

METHODS

Ninety-six patients with malocclusion who were scheduled to undergo orthodontic treatment were randomly divided into four groups. All patients were treated with square wire appliance, and 0, 50, 150, 250 g of far-distal orthodontic force were given respectively. The levels of CX3CL1 and RANKL/OPG in gingival crevicular fluid were detected in four groups after 1, 2, 3, and 4 weeks of treatment. SPSS 25.0 software package was used for statistical analysis of the date.

RESULTS

The levels of CX3CL1, RANKL and RANKL/OPG in the gingival crevicular fluid of the four groups were continuously increased after treatment for 1-3 weeks, and decreased after 4 weeks of treatment (P<0.05). The OPG in the gingival crevicular fluid was at a low level after 1-3 weeks of treatment. There was an increase after 4 weeks of treatment (P<0.05). The levels of CX3CL1, RANKL, OPG and RANKL/OPG in gingival crevicular fluid increased gradually in group A, B, C and D (P<0.05), and the differences between the groups were statistically significant (P<0.05).

CONCLUSIONS

The levels of CX3CL1 and RANKL/OPG in gingival crevicular fluid are closely related to orthodontic force and treatment time, and can be used as an index to evaluate orthodontic treatment of alveolar bone remodeling.

摘要

目的

探讨不同正畸治疗对错牙合畸形患者龈沟液趋化因子CX3CL1、核因子κB受体活化因子配体/骨保护素(RANKL/OPG)水平的影响。

方法

将96例计划接受正畸治疗的错牙合畸形患者随机分为四组。所有患者均采用方丝弓矫治器治疗,分别施加0、50、150、250g的远中向正畸力。治疗1、2、3、4周后检测四组龈沟液中CX3CL1和RANKL/OPG的水平。采用SPSS 25.0软件包对数据进行统计学分析。

结果

四组龈沟液中CX3CL1、RANKL及RANKL/OPG水平在治疗13周后持续升高,治疗4周后下降(P<0.05)。龈沟液中OPG在治疗13周时处于低水平,治疗4周后升高(P<0.05)。A、B、C、D组龈沟液中CX3CL1、RANKL、OPG及RANKL/OPG水平逐渐升高(P<0.05),组间差异有统计学意义(P<0.05)。

结论

龈沟液中CX3CL1和RANKL/OPG水平与正畸力及治疗时间密切相关,可作为评估正畸治疗牙槽骨改建的指标。

相似文献

1
[Effects of different orthodontic treatments on sputum chemokines CX3CL1, RANKL/OPG levels in patients with malocclusion].[不同正畸治疗对错牙合畸形患者痰液趋化因子CX3CL1、RANKL/OPG水平的影响]
Shanghai Kou Qiang Yi Xue. 2021 Feb;30(1):85-88.
2
[Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention].[牙龈沟液中骨保护素(OPG)和核因子κB受体激活剂配体(RANKL)在保持期对牙槽骨重塑的指示作用]
Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Feb 18;44(1):108-12.
3
Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro.正畸牙移动过程中龈沟液中RANKL和OPG的水平以及体外压缩力对牙周膜细胞释放的影响。
Orthod Craniofac Res. 2006 May;9(2):63-70. doi: 10.1111/j.1601-6343.2006.00340.x.
4
OPG and RANKL levels around miniscrew implants during orthodontic tooth movement.种植体支抗周围骨保护素和核因子-κB 受体激活配体水平在正畸牙齿移动中的变化。
Am J Orthod Dentofacial Orthop. 2013 Aug;144(2):203-9. doi: 10.1016/j.ajodo.2013.02.028.
5
Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.慢性牙周炎患者龈沟液和组织中骨保护素/核因子-κB 受体激活剂配体系统的鉴定
J Periodontal Res. 2006 Aug;41(4):354-60. doi: 10.1111/j.1600-0765.2006.00883.x.
6
Evaluation of gingival crevicular fluid and peri-implant crevicular fluid levels of sclerostin, TWEAK, RANKL and OPG.评价骨硬化蛋白、TWEAK、RANKL 和 OPG 在龈沟液和种植体周沟液中的水平。
Cytokine. 2019 Jan;113:433-439. doi: 10.1016/j.cyto.2018.10.021. Epub 2018 Oct 28.
7
Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement.正畸牙齿移动过程中衰老对龈沟液中RANKL和OPG水平的影响。
Orthod Craniofac Res. 2006 Aug;9(3):137-42. doi: 10.1111/j.1601-6343.2006.00368.x.
8
Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.白细胞介素-34 及其受体激活物核因子-kB 配体和骨保护素水平在牙周病中的新作用。
Cytokine. 2021 Aug;144:155584. doi: 10.1016/j.cyto.2021.155584. Epub 2021 May 24.
9
Gingival Crevicular Fluid Turnover Markers in Premenopausal vs Postmenopausal Women receiving Orthodontic Treatment.接受正畸治疗的绝经前与绝经后女性的龈沟液周转标志物
J Contemp Dent Pract. 2017 Oct 1;18(10):933-936. doi: 10.5005/jp-journals-10024-2152.
10
Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid.唑来膦酸治疗骨转移患者血清和龈沟液中核因子-κB 配体和骨保护素水平。
Med Oncol. 2014 Mar;31(3):837. doi: 10.1007/s12032-013-0837-8. Epub 2014 Jan 22.